Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extroducer® Infusion Catheter System for Gemcitabine Delivery in Locally Advanced Pancreatic Cancer
NCT07575191Phase 2Recruiting
- Sponsor
- Smartwise
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in pancreatic cancer (PC), sponsored by Smartwise. Started Apr 2026; status: recruiting.
02
Drugs
gemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07575191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07575191.